Looks interesting Mak. I don't believe it will be overly successful though. It's a bit like the defibrillator. All the ambulances use manual defibrillators where the trained paramedics make the clinical decision on when to shock and how many joules are required, etc.
Since then, an automatic defibrillator was design. The machine determines when to shock and when not to. It also shocks at a pre-determined output. Not as good as a trained paramedic but better than nothing.
The units are mainly found in remote areas where ambulance response times are long, and are now in most public places. Airports have them. Many sporting clubs, etc.
They are also targeted towards home personal use. But to date not many people bother. Even those with heart conditions. Maybe because it is still relatively expensive?
I view spirometry the same. The data can easily be corrupted by inproper use. The device you refer to seems to say they have algorithms to detect misuse. But honestly it's hard to differentiate between a short breathe due to incorrect technique versus a short breathe due to laboured breathing.
Somethings are just meant to be done by professionals imo. Professionals provide peace of mind. We don't want self treating society and internet doctors. Imagine the product disclaimers to handball liability incase of wrongful death.
No doubt it is still a competitor to ISN. But I think the simplicity of Wheezometer App will be advantageous, even if it does lose alot of its usefulness by being simple.
It will definately come down to price. I would hope ISN look at a low annual fee which would provide clinical/technical support and free software upgrades.
- Forums
- ASX - By Stock
- ISN
- do research
do research , page-52
Featured News
Add ISN (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online